US Patent Issued to The General Hospital on March 24 for "Glutathione trisulfide (GSSSG) in neuroprotection" (Massachusetts Inventors)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,582,693, issued on March 24, was assigned to The General Hospital Corp. (Boston).

"Glutathione trisulfide (GSSSG) in neuroprotection" was invented by Fumito Ichinose (Chestnut Hill, Mass.) and Eizo Marutani (Somerville, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods for the use of glutathione trisulfide (GSSSG) in neuroprotection, e.g., in neurodegenerative diseases and to reduce the risk of ischemic injury. The methods can be used, e.g., to reduce risk of injury to brain, spinal cord, and peripheral nerves from ischemia or low blood flow states possibly caused by surgery, trauma, and other conditions that decrease/impair blood flow and o...